APDN Partners with GenXys to Deploy Clinical Decision Support System for PGx Testing
STONY BROOK, N.Y., June 18, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a global leader in PCR-based DNA technologies, today announced that its molecular diagnostics subsidiary, Applied DNA Clinical Labs, LLC (ADCL), will utilize the GenXys Health Care Systems (GenXys) suite of clinical decision support software for interpretation and reporting [...]